Dolby Laboratories (DLB) EBITDA Margin (2009 - 2026)

Dolby Laboratories has reported EBITDA Margin for 18 years, with the latest figure at 28.55% in Q1 2026.

• For the quarter ending Q1 2026, EBITDA Margin fell 61.0% year-over-year to 28.55%; the trailing twelve-month figure through Mar 2026 stood at 18.49% (down 202.0% YoY), and the FY2025 full-year result was 19.64%, down 64.0% from the prior year.
• EBITDA Margin for Q1 2026 stood at 28.55%, up from 17.93% in the prior quarter.
• The five-year high for EBITDA Margin was 29.89% in Q1 2024, with the low at 1.2% in Q3 2023.
• Historically, EBITDA Margin has averaged 17.73% across 5 years, with a median of 15.73% in 2022.
• Annual changes were most pronounced in 2022 — EBITDA Margin slumped 1307 bps — and 2024, when it jumped 1641 bps.
• Dolby Laboratories' EBITDA Margin stood at 28.09% in 2022, then dropped by 25 bps to 20.98% in 2023, then increased by 7 bps to 22.38% in 2024, then declined by 20 bps to 17.93% in 2025, then soared by 59 bps to 28.55% in 2026.
• The last three EBITDA Margin figures came in at 28.55% (Q1 2026), 17.93% (Q4 2025), and 9.67% (Q3 2025), per Business Quant data.